Search

Jazz Pharmaceuticals PLC

Closed

SectorHealthcare

251.01 -0.49

Overview

Share price change

24h

Current

Min

247.42

Max

253.95

Key metrics

By Trading Economics

Income

1.2B

293M

Sales

-129M

1.1B

P/E

Sector Avg

2,554.3

64.641

EPS

6.34

Profit margin

27.421

Employees

2,890

EBITDA

265M

544M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+4.6% upside

Dividends

By Acuity

Next Earnings

3 Aug 2026

Market Stats

By TradingEconomics

Market Cap

3B

16B

Previous open

251.5

Previous close

251.01

News Sentiment

By Acuity

34%

66%

83 / 340 Healthcare

Jazz Pharmaceuticals PLC Chart

Past performance is not a reliable indicator of future results.

Related News

31 Jul 2026, 23:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30 Jul 2026, 19:59 UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29 Jul 2026, 18:26 UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28 Jul 2026, 23:46 UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27 Jul 2026, 19:37 UTC

Social Media

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24 Jul 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21 Jul 2026, 19:02 UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20 Jul 2026, 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

Peer Comparison

Price change

Jazz Pharmaceuticals PLC Forecast

Price Target

By TipRanks

4.6% upside

12 Months Forecast

Average 264.5 USD  4.6%

High 307 USD

Low 229 USD

Based on 18 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

18 ratings

17

Buy

1

Hold

0

Sell

Sentiment

By Acuity

83 / 340 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat